HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
BBS2
Bardet-Biedl syndrome 2
Chromosome 16 Β· 16q13
NCBI Gene: 583Ensembl: ENSG00000125124HGNC: HGNC:967UniProt: A0A804HIE1
69PubMed Papers
22Diseases
0Drugs
266Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
Golgi to plasma membrane protein transportvisual perceptionBBSomeRNA polymerase II-specific DNA-binding transcription factor bindingBardet-Biedl syndromeBardet-Biedl syndrome 2retinitis pigmentosaretinitis pigmentosa 74
✦AI Summary

BBS2 encodes a core component of the BBSome complex, a coat complex essential for primary cilium formation and function 1. The BBSome associates with Rab8 guanosine nucleotide exchange factors at the basal body, enabling Rab8-GTP-mediated docking and fusion of carrier vesicles at the ciliary base to facilitate ciliary membrane extension 2. BBS2 also regulates sonic hedgehog pathway signaling through smoothened (SMO) ciliary trafficking control. Beyond ciliary function, BBS2 negatively regulates adipogenesis, with loss of function promoting fat accumulation through PPARΞ³ and FABP4 pathway activation 3. Mutations in BBS2 cause Bardet-Biedl syndrome, a pleiotropic ciliopathy characterized by renal cysts, retinal degeneration, obesity, and skeletal anomalies 1. Notably, BBS2 mutations can present as nonsyndromic retinitis pigmentosa, suggesting tissue-specific ciliary requirements 45. A recurrent splice site mutation (c.534+1G>T) shows population-specific founder effects in Taiwanese BBS2 patients 6. Translational readthrough drugs (ataluren, amlexanox) restore full-length BBS2 protein from nonsense mutations, recovering ciliogenesis and ciliary signaling in patient fibroblasts, indicating potential therapeutic strategies for nonsense-mediated BBS2 ciliopathies 2.

Sources cited
1
BBS2 mutations cause Bardet-Biedl syndrome, a renal ciliopathy with kidney cysts and ciliary dysfunction
PMID: 33039432
2
BBSome assembly requires BBS2 and functions with Rab8 at the basal body for ciliary biogenesis; translational readthrough drugs restore BBS2 protein and ciliary function
PMID: 34365092
3
BBS2 negatively regulates adipogenesis through PPARΞ³ and FABP4 pathways in fat tissue
PMID: 35718089
4
BBS2 missense mutations cause nonsyndromic retinitis pigmentosa as well as syndromic Bardet-Biedl syndrome
PMID: 25541840
5
BBS2 variants identified in families with retinitis pigmentosa and Bardet-Biedl syndrome
PMID: 31960602
6
BBS2 c.534+1G>T is a recurrent founder mutation in Taiwanese Bardet-Biedl syndrome patients
PMID: 38671463
Disease Associationsβ“˜22
Bardet-Biedl syndromeOpen Targets
0.81Strong
Bardet-Biedl syndrome 2Open Targets
0.76Strong
retinitis pigmentosaOpen Targets
0.73Strong
retinitis pigmentosa 74Open Targets
0.73Strong
Retinal dystrophyOpen Targets
0.56Moderate
Bardet-Biedl syndrome 1Open Targets
0.53Moderate
genetic disorderOpen Targets
0.49Moderate
BBS2-related ciliopathyOpen Targets
0.49Moderate
polydactylyOpen Targets
0.46Moderate
obesityOpen Targets
0.38Weak
eye diseaseOpen Targets
0.37Weak
retinopathyOpen Targets
0.34Weak
autosomal recessive retinitis pigmentosaOpen Targets
0.33Weak
small cell lung carcinomaOpen Targets
0.07Suggestive
chronic obstructive pulmonary diseaseOpen Targets
0.07Suggestive
obesity due to melanocortin 4 receptor deficiencyOpen Targets
0.05Suggestive
frozen shoulderOpen Targets
0.04Suggestive
ovarian neoplasmOpen Targets
0.04Suggestive
leukoencephalopathy with vanishing white matter 5Open Targets
0.03Suggestive
obesity due to congenital leptin deficiencyOpen Targets
0.03Suggestive
Bardet-Biedl syndrome 2UniProt
Retinitis pigmentosa 74UniProt
Pathogenic Variants266
NM_031885.5(BBS2):c.1725del (p.Phe575fs)Pathogenic
Bardet-Biedl syndrome 2|Focal segmental glomerulosclerosis
β˜…β˜…β˜†β˜†2026β†’ Residue 575
NM_031885.5(BBS2):c.72C>G (p.Tyr24Ter)Pathogenic
BARDET-BIEDL SYNDROME 2/6, DIGENIC|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinal dystrophy|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Retinitis pigmentosa|BBS2-related disorder|not provided|Retinal disorder|Early onset severe obesity
β˜…β˜…β˜†β˜†2026β†’ Residue 24
NM_031885.5(BBS2):c.1438C>T (p.Arg480Ter)Pathogenic
Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2
β˜…β˜…β˜†β˜†2026β†’ Residue 480
NM_031885.5(BBS2):c.311A>C (p.Asp104Ala)Pathogenic
Bardet-biedl syndrome 1/2, digenic|Retinitis pigmentosa 74|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Retinitis pigmentosa|not provided|BBS2-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 104
NM_031885.5(BBS2):c.2107C>T (p.Arg703Ter)Pathogenic
Bardet-Biedl syndrome|Inborn genetic diseases|Bardet-Biedl syndrome 2|Retinitis pigmentosa 74|BBS2-related disorder|Retinal dystrophy|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74
β˜…β˜…β˜†β˜†2026β†’ Residue 703
NM_031885.5(BBS2):c.1649_1650del (p.Leu550fs)Pathogenic
Bardet-Biedl syndrome|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Bardet-Biedl syndrome 2
β˜…β˜…β˜†β˜†2026β†’ Residue 550
NM_031885.5(BBS2):c.1895G>C (p.Arg632Pro)Pathogenic
Bardet-Biedl syndrome 2|Retinitis pigmentosa 74|BBS2-related disorder|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Inborn genetic diseases|Retinal dystrophy
β˜…β˜…β˜†β˜†2026β†’ Residue 632
NM_031885.5(BBS2):c.1237C>T (p.Arg413Ter)Pathogenic
Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Bardet-Biedl syndrome 2;Retinitis pigmentosa 74|not provided|Retinal dystrophy|BBS2-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 413
NM_031885.5(BBS2):c.823C>T (p.Arg275Ter)Pathogenic
Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Retinal dystrophy|Retinitis pigmentosa 74|BBS2-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 275
NM_031885.5(BBS2):c.1780C>T (p.Arg594Ter)Pathogenic
Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|BBS2-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 594
NM_031885.5(BBS2):c.943C>T (p.Arg315Trp)Pathogenic
Bardet-biedl syndrome 2/4, digenic|Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Retinal dystrophy|Retinitis pigmentosa 74
β˜…β˜…β˜†β˜†2026β†’ Residue 315
NM_031885.5(BBS2):c.440del (p.Phe147fs)Pathogenic
Bardet-Biedl syndrome|BBS2-related disorder|Bardet-Biedl syndrome 2
β˜…β˜…β˜†β˜†2026β†’ Residue 147
NM_031885.5(BBS2):c.534+1G>TPathogenic
Bardet-Biedl syndrome 2|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|Retinal dystrophy|not provided
β˜…β˜…β˜†β˜†2025
NM_031885.5(BBS2):c.1909_1910del (p.Met637fs)Pathogenic
Bardet-Biedl syndrome 2|Retinal dystrophy|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 637
NM_031885.5(BBS2):c.612+1G>APathogenic
Bardet-Biedl syndrome 2
β˜…β˜…β˜†β˜†2025
NM_031885.5(BBS2):c.175C>T (p.Gln59Ter)Pathogenic
Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2
β˜…β˜…β˜†β˜†2025β†’ Residue 59
NM_031885.5(BBS2):c.535-2A>GPathogenic
not provided|Bardet-Biedl syndrome|BBS2-related ciliopathy
β˜…β˜…β˜†β˜†2025
NM_031885.5(BBS2):c.1397+1G>APathogenic
Bardet-Biedl syndrome|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|BBS2-related ciliopathy|Bardet-Biedl syndrome 2
β˜…β˜…β˜†β˜†2025
NM_031885.5(BBS2):c.241G>T (p.Gly81Cys)Pathogenic
Bardet-Biedl syndrome 2|Retinal dystrophy|not provided|Bardet-Biedl syndrome|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2
β˜…β˜…β˜†β˜†2025β†’ Residue 81
NM_031885.5(BBS2):c.700C>T (p.Arg234Ter)Pathogenic
Bardet-Biedl syndrome 2|Bardet-Biedl syndrome|not provided|Retinitis pigmentosa 74;Bardet-Biedl syndrome 2|Retinal dystrophy|BBS2-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 234
View on ClinVar β†—
Related Genes
AP1G1Protein interaction100%BBS5Protein interaction100%BBIP1Protein interaction100%BBS9Protein interaction100%LZTFL1Protein interaction99%BBS10Protein interaction98%
Tissue Expression6 tissues
Brain
100%
Ovary
94%
Heart
74%
Bone Marrow
45%
Lung
30%
Liver
26%
Gene Interaction Network
Click a node to explore
BBS2AP1G1BBS5BBIP1BBS9LZTFL1BBS10
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q9BXC9
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.89LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.72 [0.58–0.89]
RankingsWhere BBS2 stands among ~20K protein-coding genes
  • #6,782of 20,598
    Most Researched69
  • #241of 5,498
    Most Pathogenic Variants266 Β· top 5%
  • #8,001of 17,882
    Most Constrained (LOEUF)0.89
Genes detectedBBS2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Ciliopathies and the Kidney: A Review.
PMID: 33039432
Am J Kidney Dis Β· 2021
1.00
2
PMID: 20301537
0.90
3
PMID: 20301590
0.80
4
Application of targeted panel sequencing and whole exome sequencing for 76 Chinese families with retinitis pigmentosa.
PMID: 31960602
Mol Genet Genomic Med Β· 2020
0.70
5
Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.
PMID: 25541840
JAMA Ophthalmol Β· 2015
0.60